PresbyopiaPROSPERNCT03228199
PROductivity Study of Presbyopia Elimination in Rural-dwellers (PROSPER)
A study testing Intervention group in people with Presbyopia, run by Congdon Nathan at 1 site in India.
Trial summary
This trial seeks to establish, using a randomized, controlled design, the impact of near eyesight correction on the productivity of presbyopic agricultural workers in India, as measured by weight of tea picked. Read more about this study
- Who is it for?
- Ages 40 years and olderHealthy volunteers can take part
- Conditions the study is for
- Presbyopia
- What is being tested?
- Intervention group
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 751 participants
- Where
- 1 siteIndia
- Study dates
- 24 Jul 2017to 28 Oct 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Employee of APPL for 1 year
- Aged >= 40 years
- Habitual near visual acuity of >= 0.8M (<=6/12) at 40cm in both eyes, correctable to <=0.5M (>=6/7.5) in both eyes with near glasses
- Uncorrected distance vision >= 6/7.5 in the better-seeing eye
- The participant worked and has data available on weight of tea picked for >=10 days in the previous 4 weeks (This will largely exclude men in this setting).
- Ability to give informed consent
Who cannot join
- Eye disease detected on baseline eye exam
- Current ownership of near correction capable of improving near visual acuity to <= 0.8M (>= 6/12) in either eye
- Unlikely to complete follow-up due to unsatisfactory work performance, plans to move out of the area, etc.
- Need for distance correction to achieve distance vision of >= 6/7.5 in the better-seeing eye.
- Inability to achieve best-corrected visual acuity with spherical power glasses only (that is: need for astigmatic correction to achieve best-corrected near visual acuity)
- Persons with eye problems detected on the examination will be referred for definitive care at local facilities, and distance refractive errors will be corrected with free bifocals for those with uncorrected VA < 6/12 in the better-seeing eye.
Trial locations and contacts
1 site in 1 country.
About this study
This trial seeks to establish, using a randomized, controlled design, the impact of near eyesight correction on the productivity of presbyopic agricultural workers in India, as measured by weight of tea picked.
Read the detailed description
Main research question being addressed: To establish, using a randomized, controlled design, the impact of near eyesight correction on the productivity of presbyopic agricultural workers in India, as measured by weight of tea picked.
Primary outcomes to be measured: Change in mean daily weight of tea picked per worker during a 12 weeks period after randomisation compared to a 4 weeks baseline period prior to randomisation. (See details below under Main Outcome.)
- Background: Importance of research topic, Particular Features of setting Uncorrected presbyopia is an expensive problem for the world. Lost productivity among adults who need eyeglasses has been estimated to cost the global economy $227 billion every year, [1,2] and illiteracy may lead to a further $3 trillion in annual global economic losses. It has been shown that 74% of illiterate adults failed one or more parts of a vision screening. [3] However, in order to motivate governments, industry and other key stakeholders to invest in solving the problem of uncorrected near vision in adults, higher-quality data on the productivity impact of correction are needed. Current studies are suggestive, but carefully-performed randomized trials are still lacking in the published literature.
An unpublished University of Michigan (USA) working paper found that correcting near-vision loss with glasses yields an increase in productivity of up to 34%, though no control group was included, and the outcome assessed was not precisely defined. An unpublished impact assessment conducted by Building Resources Across Communities (BRAC), the world's largest NGO in the number of staff, concluded that 90% of individuals experiencing near-vision loss in Bangladesh encountered problems with their daily work; and, on average, 23% reported that their income was compromised.[4] In Rwanda, Lifetime Consulting \& Partners found that workers with poor vision who did not wear glasses were three times more likely to be asked by supervisors to repeat their work of sorting coffee beans than after receiving and wearing glasses.[4] Again, no control group was included, and this work has not been published. Furthermore, a Dalberg Global Development Advisors study of adults in India who had their vision corrected with glasses found that 65% reported an increase in independence in movement and travel, and 59% reported improved work productivity, [5] but these outcomes were not confirmed quantitatively or objectively. Finally, a population study of 1008 older adults in Shenyang, northern China, found that those with uncorrected presbyopia (69%) were more likely to report diminished accomplishment due to vision (P = 0.01, adjusted for age, sex, education, and distance vision) than were those without presbyopia. [6] The impact of correcting presbyopia was not studied in a prospective fashion.
In summary, available data are consistent with the idea that correcting presbyopia can lead to significant improvements in productivity among adult workers. However, in the absence of high-quality randomized trials, it is very difficult to be certain about cause and effect: it is equally plausible that the economic burden of poverty could result in failure to purchase glasses, rather than the reverse. Lack of control groups and carefully-defined productivity outcomes in many studies further hinder interpretation. Policy makers and industry partners require more convincing data in order to commit to the support of programs of vision correction.
Features of this setting:
A high proportion (> 50%) of workers have presbyopia in this large workforce, and previous projects by Vision Spring have shown that the large majority of these workers have no presbyopic correction.
The primary outcome (daily weight of tea picked) is measured and recorded by Amalgamated Tea as part of routine practice.
The work population is very stable, and data from previous years have been used for sample size calculations.
The project will be carried out during the high season (July through October) when the amount of tea picked is limited by the labourer and not by the growth of the plants. Further, these agricultural workers are strongly incentivized to pick more tea, because they are paid by weight, and thus gain in income when their personal productivity increases.
II. Experimental plan
Study design: Randomized, investigator-masked controlled trial
Methods to be used:
Population: Presbyopic (generally age >= 40 years) tea workers at the Amalgamated Plantations Pvt Ltd (APPL) in Assam, India.
Baseline data acquisition: Demographic and clinical: Age, sex, contact information, habitual and best-corrected visual acuity at near and distance; power of distance and near refractive error in each eye; workers with acuity not improving to 6/7.5 in either eye at distance will undergo dilated fundus examination and will be referred to a local collaborating facility for care if needed. Work productivity: Daily mean weight of tea picked during a 4 weeks baseline period prior to randomisation.
Recruitment and consent: Approximately 1500 APPL workers aged 40 years or more will undergo assessment of above clinical criteria ("Baseline data acquisition") by VisionSpring local staff, assisted by APPL as part of the on-going Clear Vision Workplace program. Those meeting inclusion criteria (see below) will be invited to join to the study and complete informed consent forms. Recruitment will continue until approximately 700 persons have joined the study (see sample size calculations below). Baseline work productivity will be measured as outlined above for a 4-week period).
Randomization, Balancing, and Intervention: Eligible workers completing baseline productivity assessment will be enrolled into the study, and assigned at random to one of the below groups:
Intervention Group: Will immediately receive a free pair of presbyopic glasses through the Clear Vision Workplace program. These glasses will correct the worker's vision at their own usual working distance (methodology described in the full protocol), and will not correct astigmatism. Distance refractive errors will be corrected for those with uncorrected VA < 6/12 in the better-seeing eye, but such persons will be excluded from the trial.
Control Group: Will be deferred to receive free presbyopic spectacles after the 12 weeks evaluation period.
Balance of the groups on age and baseline work productivity, will be assessed and maintained insofar as possible, and allocation concealment prior to randomisation will be ensured through the use of a secure process so that neither the participant nor the person recruiting them to the study will know in advance whether or not they will receive spectacles immediately or after 12 weeks.
Randomization methodology: Eligible workers completing baseline data collection will be enrolled into the study, and stratified into eight groups according to age (<50, >=50), sex and baseline work productivity (<median, >=median), then participants among each of the eight groups will be assigned at random to one of the study arms.
An independent statistician having no contact with participants will generate the randomization sequence using a computer system that is inaccessible until after recruitment. The participants in each stratified group will be assigned to either the intervention or control group in a 1:1 ratio with the block size of six. The participants will know their group assignment. However, the APPL staff measuring the weight and quality outcomes will be masked to a worker's group assignment by having an intermediate person receive the tea from the worker at the weighing station each day.
Main outcome and masking: The daily mean weight of tea picked will be calculated for each worker for the 4 weeks baseline and for the 12 weeks evaluation period. The difference between these two means will be calculated for each worker, and the mean of this value will be calculated for each randomised group, with the main study outcome being the difference between these values for each group. It will not be practical to mask participants to their study group assignment (the investigators do not feel that providing sham near correction of Plano power is ethical). However, the APPL staff measuring the weight outcomes will be masked to a worker's group assignment by having an intermediate person receive the tea from the worker and carry it to the weighing station each day. Secondary outcomes will include visual quality of life in both groups, self-reported wear of the study spectacles in the intervention group, self-reported purchase and use of glasses in the control group, independent compliance observations, quality of tea picked (if possible to assess) and the proportion of workers who work than less than 10 days in a month during the 12 weeks evaluation period.
Study hypothesis: Productivity gains in the Intervention Group will be significantly greater than those in the Control Group when the 12 weeks evaluation period is compared to the 4 weeks baseline period.
Sample size calculations: With two-sided significance level of P=0.05, power of 80%, a daily mean of 25.0 (SD: 5.0) kg of tea picked at baseline (among persons working >= 10 days in a month), and allowing for 20% loss to follow-up, a sample size of 160 persons (80 per group) will be sufficient to detect a 10% greater increase in daily mean weight of tea picked in the intervention group compared to the control group (primary outcome). However, in order to have sufficient data to conduct adequately powered analyses to compare the results for persons aged 40 years and above, with those for persons aged at least 45 years and at least 50 years, we will aim to recruit a total of 700 participants. These subgroup analyses will be important for informing future policy, for example, if choices need to be made about which, if any, age groups should be targeted for eyeglasses.
Statistical methods: The analysis of the primary outcome (as defined above) between randomised groups will be done with and without adjustment for potential determinants of productivity at baseline (including age and sex) and during the evaluation period (including self-reported use of glasses in the intervention group and self-reported purchase and use of glasses among the control group). The mean daily data for participants working <10 days in a month during the evaluation period will be excluded from the main analyses in sensitivity analyses to assess the impact of these workers on the overall results (both in relation to the effect estimate and its confidence interval). Main analysis will also include age-stratified analysis of participants (for example, 40-44, 45-49, 50-59, and 60 and above).
Study Roles and Monitoring: The principal investigator will be responsible for final approval of the study protocol, overall study coordination and completing the UK ethical review. The principal investigator has a long-standing working relationship with VisionSpring (VS) and extensive experience in design and execution of randomised trials on a refractive error in settings of limited resources. The principal investigator will visit India on two occasions: During the Study Preparation period and at the time of the Baseline examination. The VS India team will be responsible for coordinating fieldwork. VS has worked in India for 10 years, and with APPL since 2014, and has extensive experience in carrying out presbyopic screening and provision of near spectacles in India and a wide variety of LMIC settings. APPL will provide support for the baseline examination, administration of the intervention and the end line distribution of glasses to the Control Group. APPL will also be primarily responsible for the collection of the primary study outcome (mean daily weight of picked tea) and the secondary outcome of the quality of picked tea in both groups.
Dissemination strategy: The project management team will prepare a dissemination strategy which balances the requirements of academic audiences (peer-reviewed journal publications and conference presentations) with those of policy-makers and local patients and practitioners in both the UK and India and our NGO partners. In submitting findings to a range of academic journals, the investigators will focus on internationally-recognized journals with high impact, particularly those such as BMJ and Lancet Global Health with open access policies, making the papers more available to researchers and policy-makers in LMICs. The investigators will collaborate with the Cochrane Eyes and Vision group to help them update reviews on the economic impact of the correction of refractive error. At the conclusion of the main trial, principal results will be available in English and several Indian languages and in graphic format on a mobile-friendly project website. Results will also be shared through organizations such as our Indian research partners and various locally-active eye health NGOs.
Funding: Primary funding provided by Clearly (Clearly.World), free glasses provided by VisionSpring (VisionSpring.org).
- Conditions
- Presbyopia
- Being tested
- Intervention group, Control Group
- Keywords
- Randomised Control Trial, Productivity, Agricultural workers, India, Vision correction
- Medical subject headings
- Presbyopia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Intervention groupOther
Will immediately receive a free pair of presbyopic glasses through the Clear Vision Workplace program. These glasses will correct the worker's vision at their usual working distance, and will not correct astigmatism.
Control GroupOther
Will be deferred to receive spectacles as above, after the 12 week evaluation period.
| Study group | Role | What they receive |
|---|---|---|
| Presbyopic Glasses/ Intervention Group | Other | Immediate provision of a free pair of spherical presbyopic glasses to correct the worker's vision for optimal picking distance as measured using a chart placed at the top of a typical tea bush. Receives: Other: Intervention group |
| Control Group | Other | Will be deferred to receive spectacles as above, after the 12 weeks evaluation period. Receives: Other: Control Group |
What is being measured
The primary outcome is the main question the study is designed to answer.
The impact of near correction of the vision on productivity of agricultural workers in India will be measured.
The main outcome will be change in mean daily weight of tea picked per worker during a 12 weeks period after randomisation to intervention or control, compared to a 4 weeks period prior to the randomisation.
Measured: 4 to 5 months
Secondary outcomes (1)
The impact of near correction of the vision on productivity of agricultural workers in India
Secondary outcomes will include visual quality of life in both groups, self-reported wear of the study spectacles in the intervention group, self-reported purchase and use of glasses in the control group, independent compliance observations and the proportion of workers who work less than 10 days in a month during the 12 weeks evaluation period.
Measured: 4 to 5 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Jul 2017
- Study start24 Jul 2017
- Primary completion7 Oct 2017
- Study completion28 Oct 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (7)Papers the sponsor has linked to this study.
- Other trials for PresbyopiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomization, Balancing, and Intervention: Eligible workers completing baseline productivity assessment will be enrolled into the study, and assigned at random to one of the below groups: Intervention Group: Will immediately receive a free pair of presbyopic glasses through the Clear Vision Workplace program. These glasses will correct the worker's vision at their usual working distance by placing the vision chart on the top of a tea bush and directing the participant to stand as usual in picking tea. The gasses will not correct astigmatism. Distance refractive errors will be corrected for those with uncorrected VA \< 6/12 in the better-seeing eye. Control Group: Will be deferred to receive free presbyopic spectacles after the 12 weeks evaluation period.
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 751 participants (actual)
Sponsor and investigators
- Lead sponsor
- Congdon Nathan
- Sponsor type
- University, hospital or other
- Collaborators
- Queen's University, Belfast, Clearly, COMMUNITY EYE CARE FOUNDATION (CECF), Aravind Eye Care System, University of British Columbia, Amalgamated Plantations Private Limited, VisionSpring
- Responsible party
- Sponsor-investigator, Congdon Nathan, Sun Yat-sen University
- Investigators
- Nathan Congdon, Principal investigator, Queen's University, Belfast
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03228199
- Sponsor's protocol ID
- PROSPER (IRB - LNEH/88/2017)
- Acronym
- PROSPER
- Status last verified
- Dec 2017
- First submitted
- 3 Jun 2017
- Last updated
- 27 Dec 2017
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Fricke TR, Holden BA, Wilson DA, Schlenther G, Naidoo KS, Resnikoff S, Frick KD. Global cost of correcting vision impairment from uncorrected refractive error. Bull World Health Organ. 2012 Oct 1;90(10):728-38. doi: 10.2471/BLT.12.104034. Epub 2012 Jul 12.
PubMed 23109740Frick KD, Joy SM, Wilson DA, Naidoo KS, Holden BA. The Global Burden of Potential Productivity Loss from Uncorrected Presbyopia. Ophthalmology. 2015 Aug;122(8):1706-10. doi: 10.1016/j.ophtha.2015.04.014.
PubMed 26190438Johnson R, Zaba J. The link: Vision and illiteracy. J of Behav Optometry 1994;5:41-3
EYEIliance, Eyeglasses for global development: Bridging the visual divide. June 2016 report
Dalberg Global Development Advisors 2015. Impact study of Essilor's Eye Mitra optician programme in India (a programme of the Essilor Group's 2.5 New Vision Generation division)
Lu Q, Congdon N, He X, Murthy GV, Yang A, He W. Quality of life and near vision impairment due to functional presbyopia among rural Chinese adults. Invest Ophthalmol Vis Sci. 2011 Jun 13;52(7):4118-23. doi: 10.1167/iovs.10-6353.
PubMed 21508106Reddy PA, Congdon N, MacKenzie G, Gogate P, Wen Q, Jan C, Clarke M, Kassalow J, Gudwin E, O'Neill C, Jin L, Tang J, Bassett K, Cherwek DH, Ali R. Effect of providing near glasses on productivity among rural Indian tea workers with presbyopia (PROSPER): a randomised trial. Lancet Glob Health. 2018 Sep;6(9):e1019-e1027. doi: 10.1016/S2214-109X(18)30329-2. Epub 2018 Jul 23.
PubMed 30049615
Study at a glance
From the registry record, last updated by the sponsor on 27 Dec 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- PROductivity Study of Presbyopia Elimination in Rural-dwellers (PROSPER)
- ClinicalTrials.gov ID
- NCT03228199
- Acronym / sponsor ID
- PROSPER / PROSPER (IRB - LNEH/88/2017)
- Conditions
- Presbyopia
- Keywords
- Randomised Control Trial, Productivity, Agricultural workers, India, Vision correction
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 751 participants (actual)
- Lead sponsor
- Congdon NathanUniversity, hospital or other
- Collaborators
- Queen's University, Belfast, Clearly, COMMUNITY EYE CARE FOUNDATION (CECF), Aravind Eye Care System, University of British Columbia, Amalgamated Plantations Private Limited, VisionSpring
- Study start
- 24 Jul 2017 (actual)
- Primary completion
- 7 Oct 2017 (actual)
- Study completion
- 28 Oct 2017 (actual)
- First posted
- 24 Jul 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This trial seeks to establish, using a randomized, controlled design, the impact of near eyesight correction on the productivity of presbyopic agricultural workers in India, as measured by weight of tea picked.
Detailed description
Main research question being addressed: To establish, using a randomized, controlled design, the impact of near eyesight correction on the productivity of presbyopic agricultural workers in India, as measured by weight of tea picked.
Primary outcomes to be measured: Change in mean daily weight of tea picked per worker during a 12 weeks period after randomisation compared to a 4 weeks baseline period prior to randomisation. (See details below under Main Outcome.)
- Background: Importance of research topic, Particular Features of setting Uncorrected presbyopia is an expensive problem for the world. Lost productivity among adults who need eyeglasses has been estimated to cost the global economy $227 billion every year, [1,2] and illiteracy may lead to a further $3 trillion in annual global economic losses. It has been shown that 74% of illiterate adults failed one or more parts of a vision screening. [3] However, in order to motivate governments, industry and other key stakeholders to invest in solving the problem of uncorrected near vision in adults, higher-quality data on the productivity impact of correction are needed. Current studies are suggestive, but carefully-performed randomized trials are still lacking in the published literature.
An unpublished University of Michigan (USA) working paper found that correcting near-vision loss with glasses yields an increase in productivity of up to 34%, though no control group was included, and the outcome assessed was not precisely defined. An unpublished impact assessment conducted by Building Resources Across Communities (BRAC), the world's largest NGO in the number of staff, concluded that 90% of individuals experiencing near-vision loss in Bangladesh encountered problems with their daily work; and, on average, 23% reported that their income was compromised.[4] In Rwanda, Lifetime Consulting \& Partners found that workers with poor vision who did not wear glasses were three times more likely to be asked by supervisors to repeat their work of sorting coffee beans than after receiving and wearing glasses.[4] Again, no control group was included, and this work has not been published. Furthermore, a Dalberg Global Development Advisors study of adults in India who had their vision corrected with glasses found that 65% reported an increase in independence in movement and travel, and 59% reported improved work productivity, [5] but these outcomes were not confirmed quantitatively or objectively. Finally, a population study of 1008 older adults in Shenyang, northern China, found that those with uncorrected presbyopia (69%) were more likely to report diminished accomplishment due to vision (P = 0.01, adjusted for age, sex, education, and distance vision) than were those without presbyopia. [6] The impact of correcting presbyopia was not studied in a prospective fashion.
In summary, available data are consistent with the idea that correcting presbyopia can lead to significant improvements in productivity among adult workers. However, in the absence of high-quality randomized trials, it is very difficult to be certain about cause and effect: it is equally plausible that the economic burden of poverty could result in failure to purchase glasses, rather than the reverse. Lack of control groups and carefully-defined productivity outcomes in many studies further hinder interpretation. Policy makers and industry partners require more convincing data in order to commit to the support of programs of vision correction.
Features of this setting:
A high proportion (> 50%) of workers have presbyopia in this large workforce, and previous projects by Vision Spring have shown that the large majority of these workers have no presbyopic correction.
The primary outcome (daily weight of tea picked) is measured and recorded by Amalgamated Tea as part of routine practice.
The work population is very stable, and data from previous years have been used for sample size calculations.
The project will be carried out during the high season (July through October) when the amount of tea picked is limited by the labourer and not by the growth of the plants. Further, these agricultural workers are strongly incentivized to pick more tea, because they are paid by weight, and thus gain in income when their personal productivity increases.
II. Experimental plan
Study design: Randomized, investigator-masked controlled trial
Methods to be used:
Population: Presbyopic (generally age >= 40 years) tea workers at the Amalgamated Plantations Pvt Ltd (APPL) in Assam, India.
Baseline data acquisition: Demographic and clinical: Age, sex, contact information, habitual and best-corrected visual acuity at near and distance; power of distance and near refractive error in each eye; workers with acuity not improving to 6/7.5 in either eye at distance will undergo dilated fundus examination and will be referred to a local collaborating facility for care if needed. Work productivity: Daily mean weight of tea picked during a 4 weeks baseline period prior to randomisation.
Recruitment and consent: Approximately 1500 APPL workers aged 40 years or more will undergo assessment of above clinical criteria ("Baseline data acquisition") by VisionSpring local staff, assisted by APPL as part of the on-going Clear Vision Workplace program. Those meeting inclusion criteria (see below) will be invited to join to the study and complete informed consent forms. Recruitment will continue until approximately 700 persons have joined the study (see sample size calculations below). Baseline work productivity will be measured as outlined above for a 4-week period).
Randomization, Balancing, and Intervention: Eligible workers completing baseline productivity assessment will be enrolled into the study, and assigned at random to one of the below groups:
Intervention Group: Will immediately receive a free pair of presbyopic glasses through the Clear Vision Workplace program. These glasses will correct the worker's vision at their own usual working distance (methodology described in the full protocol), and will not correct astigmatism. Distance refractive errors will be corrected for those with uncorrected VA < 6/12 in the better-seeing eye, but such persons will be excluded from the trial.
Control Group: Will be deferred to receive free presbyopic spectacles after the 12 weeks evaluation period.
Balance of the groups on age and baseline work productivity, will be assessed and maintained insofar as possible, and allocation concealment prior to randomisation will be ensured through the use of a secure process so that neither the participant nor the person recruiting them to the study will know in advance whether or not they will receive spectacles immediately or after 12 weeks.
Randomization methodology: Eligible workers completing baseline data collection will be enrolled into the study, and stratified into eight groups according to age (<50, >=50), sex and baseline work productivity (<median, >=median), then participants among each of the eight groups will be assigned at random to one of the study arms.
An independent statistician having no contact with participants will generate the randomization sequence using a computer system that is inaccessible until after recruitment. The participants in each stratified group will be assigned to either the intervention or control group in a 1:1 ratio with the block size of six. The participants will know their group assignment. However, the APPL staff measuring the weight and quality outcomes will be masked to a worker's group assignment by having an intermediate person receive the tea from the worker at the weighing station each day.
Main outcome and masking: The daily mean weight of tea picked will be calculated for each worker for the 4 weeks baseline and for the 12 weeks evaluation period. The difference between these two means will be calculated for each worker, and the mean of this value will be calculated for each randomised group, with the main study outcome being the difference between these values for each group. It will not be practical to mask participants to their study group assignment (the investigators do not feel that providing sham near correction of Plano power is ethical). However, the APPL staff measuring the weight outcomes will be masked to a worker's group assignment by having an intermediate person receive the tea from the worker and carry it to the weighing station each day. Secondary outcomes will include visual quality of life in both groups, self-reported wear of the study spectacles in the intervention group, self-reported purchase and use of glasses in the control group, independent compliance observations, quality of tea picked (if possible to assess) and the proportion of workers who work than less than 10 days in a month during the 12 weeks evaluation period.
Study hypothesis: Productivity gains in the Intervention Group will be significantly greater than those in the Control Group when the 12 weeks evaluation period is compared to the 4 weeks baseline period.
Sample size calculations: With two-sided significance level of P=0.05, power of 80%, a daily mean of 25.0 (SD: 5.0) kg of tea picked at baseline (among persons working >= 10 days in a month), and allowing for 20% loss to follow-up, a sample size of 160 persons (80 per group) will be sufficient to detect a 10% greater increase in daily mean weight of tea picked in the intervention group compared to the control group (primary outcome). However, in order to have sufficient data to conduct adequately powered analyses to compare the results for persons aged 40 years and above, with those for persons aged at least 45 years and at least 50 years, we will aim to recruit a total of 700 participants. These subgroup analyses will be important for informing future policy, for example, if choices need to be made about which, if any, age groups should be targeted for eyeglasses.
Statistical methods: The analysis of the primary outcome (as defined above) between randomised groups will be done with and without adjustment for potential determinants of productivity at baseline (including age and sex) and during the evaluation period (including self-reported use of glasses in the intervention group and self-reported purchase and use of glasses among the control group). The mean daily data for participants working <10 days in a month during the evaluation period will be excluded from the main analyses in sensitivity analyses to assess the impact of these workers on the overall results (both in relation to the effect estimate and its confidence interval). Main analysis will also include age-stratified analysis of participants (for example, 40-44, 45-49, 50-59, and 60 and above).
Study Roles and Monitoring: The principal investigator will be responsible for final approval of the study protocol, overall study coordination and completing the UK ethical review. The principal investigator has a long-standing working relationship with VisionSpring (VS) and extensive experience in design and execution of randomised trials on a refractive error in settings of limited resources. The principal investigator will visit India on two occasions: During the Study Preparation period and at the time of the Baseline examination. The VS India team will be responsible for coordinating fieldwork. VS has worked in India for 10 years, and with APPL since 2014, and has extensive experience in carrying out presbyopic screening and provision of near spectacles in India and a wide variety of LMIC settings. APPL will provide support for the baseline examination, administration of the intervention and the end line distribution of glasses to the Control Group. APPL will also be primarily responsible for the collection of the primary study outcome (mean daily weight of picked tea) and the secondary outcome of the quality of picked tea in both groups.
Dissemination strategy: The project management team will prepare a dissemination strategy which balances the requirements of academic audiences (peer-reviewed journal publications and conference presentations) with those of policy-makers and local patients and practitioners in both the UK and India and our NGO partners. In submitting findings to a range of academic journals, the investigators will focus on internationally-recognized journals with high impact, particularly those such as BMJ and Lancet Global Health with open access policies, making the papers more available to researchers and policy-makers in LMICs. The investigators will collaborate with the Cochrane Eyes and Vision group to help them update reviews on the economic impact of the correction of refractive error. At the conclusion of the main trial, principal results will be available in English and several Indian languages and in graphic format on a mobile-friendly project website. Results will also be shared through organizations such as our Indian research partners and various locally-active eye health NGOs.
Funding: Primary funding provided by Clearly (Clearly.World), free glasses provided by VisionSpring (VisionSpring.org).
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 2
- Model description
- Randomization, Balancing, and Intervention: Eligible workers completing baseline productivity assessment will be enrolled into the study, and assigned at random to one of the below groups: Intervention Group: Will immediately receive a free pair of presbyopic glasses through the Clear Vision Workplace program. These glasses will correct the worker's vision at their usual working distance by placing the vision chart on the top of a tea bush and directing the participant to stand as usual in picking tea. The gasses will not correct astigmatism. Distance refractive errors will be corrected for those with uncorrected VA < 6/12 in the better-seeing eye. Control Group: Will be deferred to receive free presbyopic spectacles after the 12 weeks evaluation period.
| Arm | Type | Receives |
|---|---|---|
| Presbyopic Glasses/ Intervention Group | Other | Other: Intervention groupImmediate provision of a free pair of spherical presbyopic glasses to correct the worker's vision for optimal picking distance as measured using a chart placed at the top of a typical tea bush. |
| Control Group | Other | Other: Control GroupWill be deferred to receive spectacles as above, after the 12 weeks evaluation period. |
Who may qualify
- Ages
- 40 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Employee of APPL for 1 year
- Aged >= 40 years
- Habitual near visual acuity of >= 0.8M (<=6/12) at 40cm in both eyes, correctable to <=0.5M (>=6/7.5) in both eyes with near glasses
- Uncorrected distance vision >= 6/7.5 in the better-seeing eye
- The participant worked and has data available on weight of tea picked for >=10 days in the previous 4 weeks (This will largely exclude men in this setting).
Key exclusion criteria (6 listed)
- Eye disease detected on baseline eye exam
- Current ownership of near correction capable of improving near visual acuity to <= 0.8M (>= 6/12) in either eye
- Unlikely to complete follow-up due to unsatisfactory work performance, plans to move out of the area, etc.
- Need for distance correction to achieve distance vision of >= 6/7.5 in the better-seeing eye.
- Inability to achieve best-corrected visual acuity with spherical power glasses only (that is: need for astigmatic correction to achieve best-corrected near visual acuity)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Intervention groupWill immediately receive a free pair of presbyopic glasses through the Clear Vision Workplace program. These glasses will correct the worker's vision at their usual working distance, and will not correct astigmatism. | Other | Presbyopic Glasses/ Intervention Group |
| Control GroupWill be deferred to receive spectacles as above, after the 12 week evaluation period. | Other | Control Group |
Primary outcome
The impact of near correction of the vision on productivity of agricultural workers in India will be measured.
Time frame: 4 to 5 months
The main outcome will be change in mean daily weight of tea picked per worker during a 12 weeks period after randomisation to intervention or control, compared to a 4 weeks period prior to the randomisation.
1 secondary outcome
The impact of near correction of the vision on productivity of agricultural workers in India
Time frame: 4 to 5 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Dec 2017.
- Results publication: PubMed 23109740Fricke TR, Holden BA, Wilson DA, Schlenther G, Naidoo KS, Resnikoff S, Frick KD. Global cost of correcting vision impairment from uncorrected refractive error. Bull World Health Organ. 2012 Oct 1;90(10):728-38. doi: 10.2471/BLT.12.104034. Epub 2012 Jul 12.
- Results publication: PubMed 26190438Frick KD, Joy SM, Wilson DA, Naidoo KS, Holden BA. The Global Burden of Potential Productivity Loss from Uncorrected Presbyopia. Ophthalmology. 2015 Aug;122(8):1706-10. doi: 10.1016/j.ophtha.2015.04.014.
- Results publicationJohnson R, Zaba J. The link: Vision and illiteracy. J of Behav Optometry 1994;5:41-3
- Results publicationEYEIliance, Eyeglasses for global development: Bridging the visual divide. June 2016 report
- Results publicationDalberg Global Development Advisors 2015. Impact study of Essilor's Eye Mitra optician programme in India (a programme of the Essilor Group's 2.5 New Vision Generation division)
- Results publication: PubMed 21508106Lu Q, Congdon N, He X, Murthy GV, Yang A, He W. Quality of life and near vision impairment due to functional presbyopia among rural Chinese adults. Invest Ophthalmol Vis Sci. 2011 Jun 13;52(7):4118-23. doi: 10.1167/iovs.10-6353.
- Derived from this study: PubMed 30049615Reddy PA, Congdon N, MacKenzie G, Gogate P, Wen Q, Jan C, Clarke M, Kassalow J, Gudwin E, O'Neill C, Jin L, Tang J, Bassett K, Cherwek DH, Ali R. Effect of providing near glasses on productivity among rural Indian tea workers with presbyopia (PROSPER): a randomised trial. Lancet Glob Health. 2018 Sep;6(9):e1019-e1027. doi: 10.1016/S2214-109X(18)30329-2. Epub 2018 Jul 23.
- Individual participant dataSharing planned: No
Related trials for Presbyopia
Recruiting
Evaluation of Functional Superiority of the Morrow eProgressive
Presbyopia
Active, not recruiting
Clinical Trial With Artiflex Presbyopic (Artiplus)
Presbyopia, Ametropia
Recruiting
VisDura VisAbility™ Micro Insert System Pre-market Clinical Trial
Presbyopia
Recruiting
Volumetric Visual Fields at Intermediate and Near Distances in Presbyopic Patients Using Occupational and General-Purpose Progressive Addition Lenses
Presbyopia
Recruiting
Volumetric Visual Fields at Different Distances in Presbyopic Patients Using Occupational (PC-133 and PC-200) and General-Purpose Progressive Addition Lenses
Presbyopia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Nathan Congdon principal investigator
Queen's University, Belfast
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Intervention group in people with Presbyopia, run by Congdon Nathan at 1 site in India.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The impact of near correction of the vision on productivity of agricultural workers in India will be measured. (time frame: 4 to 5 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03228199, which also lists 7 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Dec 2017.